1271 related articles for article (PubMed ID: 28141913)
1. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; De Jaegere AP; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
[TBL] [Abstract][Full Text] [Related]
2. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; van de Loo M; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887
[TBL] [Abstract][Full Text] [Related]
3. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
[TBL] [Abstract][Full Text] [Related]
4. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338
[TBL] [Abstract][Full Text] [Related]
6. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
[TBL] [Abstract][Full Text] [Related]
7. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
8. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.
Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547
[TBL] [Abstract][Full Text] [Related]
9. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
[TBL] [Abstract][Full Text] [Related]
10. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
[TBL] [Abstract][Full Text] [Related]
11. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
[TBL] [Abstract][Full Text] [Related]
12. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
[TBL] [Abstract][Full Text] [Related]
13. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
[TBL] [Abstract][Full Text] [Related]
16. Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.
Shah VS; Ohlsson A; Halliday HL; Dunn M
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001969. PubMed ID: 28052185
[TBL] [Abstract][Full Text] [Related]
17. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2007 Oct; (4):CD002057. PubMed ID: 17943765
[TBL] [Abstract][Full Text] [Related]
18. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
[TBL] [Abstract][Full Text] [Related]
19. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2012 May; (5):CD002057. PubMed ID: 22592682
[TBL] [Abstract][Full Text] [Related]
20. Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.
Williams MJ; Ramson JA; Brownfoot FC
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD006764. PubMed ID: 35943347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
